Amicus Therapeutics Inc (FOLD)
10.66
-0.05
(-0.47%)
USD |
NASDAQ |
Apr 24, 09:47
Amicus Therapeutics Price to Book Value: 19.66 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 23, 2024 | 19.75 |
April 22, 2024 | 19.95 |
April 19, 2024 | 19.57 |
April 18, 2024 | 19.05 |
April 17, 2024 | 19.46 |
April 16, 2024 | 19.47 |
April 15, 2024 | 19.66 |
April 12, 2024 | 19.70 |
April 11, 2024 | 20.69 |
April 10, 2024 | 20.78 |
April 09, 2024 | 21.67 |
April 08, 2024 | 21.39 |
April 05, 2024 | 21.61 |
April 04, 2024 | 21.13 |
April 03, 2024 | 20.97 |
April 02, 2024 | 20.97 |
April 01, 2024 | 21.67 |
March 28, 2024 | 21.72 |
March 27, 2024 | 21.87 |
March 26, 2024 | 21.08 |
March 25, 2024 | 21.28 |
March 22, 2024 | 21.26 |
March 21, 2024 | 21.56 |
March 20, 2024 | 22.13 |
March 19, 2024 | 21.83 |
Date | Value |
---|---|
March 18, 2024 | 21.36 |
March 15, 2024 | 21.17 |
March 14, 2024 | 21.28 |
March 13, 2024 | 21.78 |
March 12, 2024 | 21.74 |
March 11, 2024 | 22.37 |
March 08, 2024 | 22.68 |
March 07, 2024 | 22.66 |
March 06, 2024 | 23.24 |
March 05, 2024 | 24.62 |
March 04, 2024 | 24.82 |
March 01, 2024 | 24.51 |
February 29, 2024 | 23.64 |
February 28, 2024 | 23.88 |
February 27, 2024 | 25.54 |
February 26, 2024 | 25.41 |
February 23, 2024 | 24.95 |
February 22, 2024 | 24.71 |
February 21, 2024 | 25.01 |
February 20, 2024 | 25.26 |
February 16, 2024 | 25.38 |
February 15, 2024 | 25.82 |
February 14, 2024 | 24.31 |
February 13, 2024 | 23.60 |
February 12, 2024 | 25.24 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.422
Minimum
Sep 27 2019
36.90
Maximum
Jun 14 2023
15.35
Average
11.13
Median
Price to Book Value Benchmarks
TG Therapeutics Inc | 13.75 |
Geron Corp | 7.884 |
Vanda Pharmaceuticals Inc | 0.4910 |
Fate Therapeutics Inc | 1.207 |
Editas Medicine Inc | 1.291 |
Price to Book Value Related Metrics
PS Ratio | 7.878 |
Price | 10.66 |
Earnings Yield | -4.78% |
Market Cap | 3.149B |